The Medicines for Human Use (Clinical Trials) Regulations 2004 No. 1031

SCHEDULE 6 U.K. PARTICULARS THAT MUST ACCOMPANY AN APPLICATION FOR A MANUFACTURING AUTHORISATION

[F1 3A.   Where the application relates to the inactivation of viral or non-conventional agents, a statement of the manufacturing process to which the authorisation is to relate.] U.K.

Textual Amendments

F1 Sch. 6 para. 3A inserted (29.8.2006) by The Medicines for Human Use (Clinical Trials) Amendment Regulations 2006 (S.I. 2006/1928), regs. 1(1), 31(b)